Micro-Sphere to boost its spray drying capabilities

28 Oct 2019

CDMO to invest over €3 million in GMP facility expansion.

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes.

Micro-Sphere to boost its spray drying capabilities

Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to increased market demand for spray drying and capsule filling for dry powder inhalers.

The new production line, expected to be operational by Q1 2021, is Micro-Sphere’s fifth and will allow the CDMO to handle larger quantities of pharmaceutical powders and commercial volumes of finished dosage forms.

Commenting on the investment, Michael Grassberger, Managing Director at Micro-Sphere said: “Our decision to invest has been fuelled by greater demand for spray drying services and we expect it will generate significant benefits for our clients. Our flexibility is key to our success and this investment allows us to maintain that competitive advantage.”

The Swiss facility, already home to some of the world’s leading spray drying and capsule filling technologies, will also benefit from the introduction of a new enterprise resource planning (ERP) system and ‘Chromeleon’ a Chromatografy Data System (CDS) software to support the QC Lab workflow.

Both software systems will bring significant cost and time savings to the business and streamline process efficiency.

Michael Grassberger added: “This year we have focused on making the necessary investments to prepare Micro-Sphere for growth in 2019 and beyond. As well as investing in new machinery to increase our capabilities and expertise, we have also made significant investment into the latest technology. This includes investing in software platforms to ensure the most efficient and robust quality and documentation management systems are in place.

“At Micro-Sphere we’re committed to client satisfaction and ensuring our customers continue to receive the efficient and flexible service that they’re used to, so we’re always looking for ways to further improve our operations to allow us to better cater for their projects.

“This investment further demonstrates our commitment to meeting and exceeding the expectations of our customers and our experienced team are very excited to bring these investments into operation.”

Read More

Related news

Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more 
KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients

12 May 2020

Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.

Read more 
Characterizing virus and virus-like particles

Characterizing virus and virus-like particles

12 May 2020

New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.

Read more 
Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand

12 May 2020

CDMO says it has made "notable changes" to its supply chain processes to ensure continuing supply of medicines during COVID-19 pandemic

Read more 
AI technology company launches with Novartis and Sarepta deals

AI technology company launches with Novartis and Sarepta deals

11 May 2020

Collaborations focus on gene therapies for serious eye and muscle diseases using Dyno’s CapsidMap artificial intelligence platform to design AAV vectors.

Read more 
Demand for immunity products to be sustained long-term says SIRIO

Demand for immunity products to be sustained long-term says SIRIO

11 May 2020

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19.

Read more